By Michael Gwarisa Zimbabwe continues to lose over 1,000 women to cervical cancer annually, with data showing that an estimated 3,043 women are diagnosed with the disease each year. Despite this grim reality, access to screening services for women in Zimbabwe remains a challenge due to a myriad of factors, including lack of knowledge and awareness, inaccessible health services, the pain and discomfort of pelvic examinations, and societal stigma and discrimination. To boost cervical cancer screening, the government has introduced various interventions, including the use of Human Papillomavirus (HPV) DNA…
Read MoreZimbabwe Medical Doctor Launches ColpoPen, An AI Tool To Screen Cervical Cancer
